A Study Comparing the Dulaglutide Pen and the Semaglutide Pen

Clinical trial NCT03724981 · COMPLETED

Trial details

NCT number: NCT03724981
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2018-10-18
Primary completion: 2019-04-12
Enrollment: 312

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.